These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results
Co-founder and CEO of 10x Genomics. “Despite these challenges, I am confident that the steps we are taking will enable us to ...
Hosted on MSN2mon
10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right Now
Looking forward, Chris Garabedian, CEO of Xontogeny and Venture portfolio ... (see more details here) 10x Genomics, Inc. (NASDAQ:TXG) is a U.S.-based life science technology company.
Business Insider3y
Biotech founders are turning to Deep Nishar as a must-have investor. The SoftBank exec explains the strategy behind his winning bets.
"Deep is very deliberate," 10x Genomics cofounder and CEO Serge Saxonov told Insider. 10x Genomics was one of Nishar's first investments after joining SoftBank. "The stories I read about Masa ...
Seeking Alpha26d
10x Genomics: Struggling Amid Operational Challenges
10x Genomics excels in single-cell and spatial ... In the latest earnings call, CEO Serge Saxonov suggested that flexibility in pricing was a core area of focus for management in upcoming product ...
GEN3d
After a Year of Launches, 10x Refocuses on Customer Support, Biopharma Market Growth
CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales ...
10x Genomics (TXG) Receives a Hold from Bank of America Securities
In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on 10x Genomics (TXG – Research Report).
Cathie Wood’s ARK Investment buys 370K shares of 10x Genomics today
EST Cathie Wood’s ARK Investment buys 370K shares of 10x Genomics (TXG) todayInvest with Confidence: Follow TipRanks' Top Wall Street ...
Nisa Investment Advisors LLC Acquires New Position in 10x Genomics, Inc. (NASDAQ:TXG)
Nisa Investment Advisors LLC acquired a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) in the 4th quarter, HoldingsChannel reports. The firm acquired 16,500 shares of the ...